LSK BioPartners, Inc

LSK BioPartners, Inc

  • 215 S State St Ste 100B
  • Salt Lake City, Utah
  • 84111-2335

Description

LSK BioPartners, Inc. (dba “LSK BioPharma” and “LSKB”) is an international healthcare product development company. LSKB is dedicated to creating and adding value to new and innovative healthcare products. The Company is managed by industry experts who have a successful track record of developing innovative products.

LSKB’s business strategy is focused on development of healthcare products in areas of need such as oncology. LSKB is developing a targetted cancer drug YN968D1 (apatinib mesylate) as well as providing product development services to international pharmaceutical companies. LSKB’s management has extensive international experience in pharmaceutical product development. This experience includes business development, US, EU and Korean regulatory practices, and preclinical and clinical development. LSKB’s management is leveraging its experience, reputation and contacts to build a unique diversified business which contributes to the development of new health care products.

LSKB was founded in 2005 and is a privately-held corporation based in Salt Lake City, Utah.

Products & services

Similar companies nearby